Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Deal Allows Dr. Reddy’s to Sell Depression Pill in U.S.
Bloomberg
Monday, April 25, 2011 - 9:12am
tags:
Dr Reddy's, Pfizer, Wyeth, generics, Effexor XR, antidepressants
GW Pharma gets US patent for Sativex in cancer pain
pharmabiz
Saturday, April 23, 2011 - 11:18am
tags:
GW Pharma, Sativex, pain management
Baxter's First Quarter Financial Results Exceed Guidance
PharmPro
Saturday, April 23, 2011 - 11:16am
tags:
Baxter International, earnings
Pfizer, Shanghai Pharma sign MoU for potential strategic partnership
pharmabiz
Saturday, April 23, 2011 - 11:15am
tags:
Pfizer, Shanghai Pharmaceutical
GlaxoSmithKline Biologicals looking to acquire Biological E Limited's vaccine division
Invest In India
Saturday, April 23, 2011 - 11:14am
tags:
GSK, Biological E, vaccines
Watson confirms Welchol patent challenge
pharmabiz
Saturday, April 23, 2011 - 11:13am
tags:
Watson Pharmaceuticals, Welchol, Daiichi Sankyo, Genzyme
Biogen Idec's MS Drug Appears to Have an Edge
Motley Fool
Saturday, April 23, 2011 - 11:09am
tags:
Biogen Idec, multiple sclerosis, BG-12, Gelenya, Novartis
Valeant Pharmaceuticals Responds to Cephalon Board's Letter
Bradenton Herald, FL
Saturday, April 23, 2011 - 11:08am
tags:
Valeant Pharmaceuticals, Cephalon, M&A
Regulatory Update - GSK and Valeant Respond to FDA on Ezogabine
PharmaLive
Saturday, April 23, 2011 - 11:06am
tags:
GSK, Valeant Pharmaceuticals, ezogabine, epilepsy
Mylan Launches Generic Version of Famvir® Tablets
PR-USA.net
Saturday, April 23, 2011 - 11:04am
tags:
Mylan, Famvir, Novartis
Dr Reddy’s Settles Patent Dispute With Pfizer’s Unit, PTI Says
Bloomberg
Saturday, April 23, 2011 - 11:01am
tags:
Dr Reddy's, Pfizer, Effexor XR
Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants
PR NewsWire
Saturday, April 23, 2011 - 10:59am
tags:
Sanofi, Menactra, meningococcal conjugate vaccine
Pharma's Most Perilous Pipelines
Motley Fool
Saturday, April 23, 2011 - 10:58am
tags:
Teva Pharmaceuticals, Eli Lilly, Novartis, GSK, AstraZeneca, Pfizer
Pfizer’s Key Drug Walks A Tightrope
Forbes
Saturday, April 23, 2011 - 10:56am
tags:
Pfizer, tofacitinib, rheumatoid arthritis
If Rationing is So Great, Why Does Britain Have Higher Cost Growth Than the U.S.?
Forbes
Saturday, April 23, 2011 - 10:55am
tags:
health care reform
Merck's Risky Bet on Research
Bloomberg
Saturday, April 23, 2011 - 10:51am
tags:
Merck, R&D
Crunching the Data: Seven Big Pharmas With Consistent Dividends
Seeking Alpha
Saturday, April 23, 2011 - 10:50am
tags:
Bristol-Myers Squibb, Abbott Laboratories, JNJ, AstraZeneca, Eli Lilly, Merck
Vanda Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 5, 2011
Yahoo/PR NewsWire
Saturday, April 23, 2011 - 10:48am
tags:
Vanda, earnings
Idera Pharmaceuticals Delays Initiation of Phase 2 Clinical Trial of IMO-2125 in Treatment-Naïve HCV Patients
Yahoo/BusinessWire
Saturday, April 23, 2011 - 10:47am
tags:
Idera Pharmaceuticals, IMO-2125, HCV, toll-like Receptor (TLR) 9 agonist
BioCryst to Present New BCX4208 Gout Results at the Annual European Congress of Rheumatology
Yahoo/BusinessWire
Saturday, April 23, 2011 - 10:46am
tags:
gout, Biocryst, BCX4208, purine nucleoside phosphorylase inhibitor

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.